These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 6290048

  • 21. Extensive esterification of adrenal C19-delta 5-sex steroids to long-chain fatty acids in the ZR-75-1 human breast cancer cell line.
    Poulin R, Poirier D, Merand Y, Thériault C, Bélanger A, Labrie F.
    J Biol Chem; 1989 Jun 05; 264(16):9335-43. PubMed ID: 2524485
    [Abstract] [Full Text] [Related]

  • 22. Aminoglutethimide in the treatment of metastatic breast cancer.
    Troner MB.
    Cancer Res; 1982 Aug 05; 42(8 Suppl):3402s-3404s. PubMed ID: 7083206
    [Abstract] [Full Text] [Related]

  • 23. Randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer.
    Lipton A, Harvey HA, Santen RJ, Boucher A, White D, Bernath A, Dixon R, Richards G, Shafik A.
    Cancer Res; 1982 Aug 05; 42(8 Suppl):3434s-3436s. PubMed ID: 7044526
    [Abstract] [Full Text] [Related]

  • 24. Aminoglutethimide in the treatment of advanced postmenopausal breast cancer.
    Harris AL, Powles TJ, Smith IE.
    Cancer Res; 1982 Aug 05; 42(8 Suppl):3405s-3408s. PubMed ID: 7083207
    [Abstract] [Full Text] [Related]

  • 25. Adequacy of estrogen suppression with aminoglutethimide and hydrocortisone as treatment of human breast cancer: correlation of hormonal data with clinical responses.
    Santen RJ, Worgul TJ, Samojlik E, Boucher AE, Lipton A, Harvey H.
    Cancer Res; 1982 Aug 05; 42(8 Suppl):3397s-3401s. PubMed ID: 7083205
    [Abstract] [Full Text] [Related]

  • 26. Influence of ACTH on aminoglutethimide induced reduction of plasma steroids in postmenopausal breast cancer.
    Bruning PF, Bonfrer JM, De Jong-Bakker M, Nooyen W.
    J Steroid Biochem; 1984 Sep 05; 21(3):293-8. PubMed ID: 6092781
    [Abstract] [Full Text] [Related]

  • 27. [Induction of thymidine kinase synthesis by 5-androstene-3 beta,17 beta-diol in the uterus of the immature rat].
    Leroy B, Maquaire E, Samperez S, Jouan P.
    C R Seances Soc Biol Fil; 1984 Sep 05; 178(4):348-54. PubMed ID: 6241012
    [Abstract] [Full Text] [Related]

  • 28. Endocrine and therapeutic effects of aminoglutethimide in premenopausal patients with breast cancer.
    Harris AL, Dowsett M, Jeffcoate SL, McKinna JA, Morgan M, Smith IE.
    J Clin Endocrinol Metab; 1982 Oct 05; 55(4):718-22. PubMed ID: 6213633
    [Abstract] [Full Text] [Related]

  • 29. In vivo and in vitro pharmacological studies of aminoglutethimide as an aromatase inhibitor.
    Santen RJ, Santner SJ, Tilsen-Mallett N, Rosen HR, Samojlik E, Veldhuis JD.
    Cancer Res; 1982 Aug 05; 42(8 Suppl):3353s-3359s. PubMed ID: 7083200
    [Abstract] [Full Text] [Related]

  • 30. Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma.
    Santen RJ, Santner S, Davis B, Veldhuis J, Samojlik E, Ruby E.
    J Clin Endocrinol Metab; 1978 Dec 05; 47(6):1257-65. PubMed ID: 263348
    [No Abstract] [Full Text] [Related]

  • 31. Hydrocortisone alone vs hydrocortisone plus aminoglutethimide: a comparison of the endocrine effects in postmenopausal breast cancer.
    Harris AL, Dowsett M, Smith IE, Jeffcoate S.
    Eur J Cancer Clin Oncol; 1984 Apr 05; 20(4):463-9. PubMed ID: 6233150
    [Abstract] [Full Text] [Related]

  • 32. Metabolism of 17 beta-estradiol and the adrenal-derived estrogen 5-androstene-3 beta,17 beta-diol (hermaphrodiol) in human mammary cell lines.
    Adams JB, Martyn P, Lee FT, Phillips NS, Smith DL.
    Ann N Y Acad Sci; 1990 Apr 05; 595():93-105. PubMed ID: 2375614
    [No Abstract] [Full Text] [Related]

  • 33. Androstenedione and androst-5-ene-3 beta,17 beta-diol stimulate DMBA-induced rat mammary tumors--role of aromatase.
    Dauvois S, Labrie F.
    Breast Cancer Res Treat; 1989 Jan 05; 13(1):61-9. PubMed ID: 2495831
    [Abstract] [Full Text] [Related]

  • 34. Dehydroepiandrosterone: kinetics of metabolism in normal men and women.
    Bird CE, Murphy J, Boroomand K, Finnis W, Dressel D, Clark AF.
    J Clin Endocrinol Metab; 1978 Oct 05; 47(4):818-22. PubMed ID: 162518
    [Abstract] [Full Text] [Related]

  • 35. [The use of aminoglutethimide (orimeten) in disseminated breast cancer].
    Nadezhdina TM, Vyshinskaia GV, Lichinitser MR, Bassalyk LS, Garin AM.
    Vopr Onkol; 1987 Oct 05; 33(5):79-82. PubMed ID: 3590672
    [Abstract] [Full Text] [Related]

  • 36. Pancytopenia induced by aminoglutethimide in the treatment of breast cancer.
    Lawrence B, Santen RJ, Lipton A, Harvey HA, Hamilton R, Mercurio T.
    Cancer Treat Rep; 1978 Oct 05; 62(10):1581-3. PubMed ID: 213192
    [Abstract] [Full Text] [Related]

  • 37. Induction of aromatase expression by aminoglutethimide, an aromatase inhibitor that is used to treat breast cancer in postmenopausal women.
    Kao YC, Okubo T, Sun XZ, Chen S.
    Anticancer Res; 1999 Oct 05; 19(3A):2049-56. PubMed ID: 10470147
    [Abstract] [Full Text] [Related]

  • 38. Medical adrenalectomy with aminoglutethimide-cortisol in the treatment of metastatic breast carcinoma.
    Paridaens R, Van Haelen C, Heuson JC.
    Eur J Cancer (1965); 1980 Oct 05; Suppl 1():103-6. PubMed ID: 7318860
    [No Abstract] [Full Text] [Related]

  • 39. [Radioimmunoassay of 5-androstene-3 beta, 17 beta-diol in plasma and breast cyst fluid].
    Bournique B, Nahoul K, Adeline J, Scholler R.
    Pathol Biol (Paris); 1986 Oct 05; 34(8):930-6. PubMed ID: 3537936
    [Abstract] [Full Text] [Related]

  • 40. Trial of aminoglutethimide vs hydrocortisone as second-line hormone treatment of advanced breast cancer.
    Mercer PM, Ebbs SR, Fraser SC, Coltart RS, Bates T.
    Eur J Surg Oncol; 1993 Jun 05; 19(3):254-8. PubMed ID: 8314383
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.